BUSINESSWEEK ONLINE : NOVEMBER 27, 2000 ISSUE
INTERNATIONAL BUSINESS Revamping Aventis AGROCHEMICALS Maker of the controversial StarLink bioengineered corn (left), Aventis owns the second-largest agrochemicals business in the world. But executives say they'll spin it off and focus on drugs. U.S. SALES Ranked 12th in the U.S. by sales, it needs to establish a stronger position in the world's most lucrative prescription-drug market--and pronto. PIPELINE Aventis will need to license new drugs from biotechnology companies or rival drug companies to ensure steady sales growth. DATA: COMPANY REPORTS, BUSINESS WEEK _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _					RELATED ITEMS An About-Face at Aventis TABLE: Revamping Aventis INTERACT E-Mail to Business Week Online

Copyright 2000-2008, by The McGraw-Hill Companies Inc. All rights reserved. Terms of Use   Privacy Notice